ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. - Stecklein SR; Kimler BF; Yoder R; Schwensen K; Staley JM; Khan QJ; O'Dea AP; Nye LE; Elia M; Heldstab J; Home T; Hyter S; et al. (NPJ breast cancer, 2023)